Disclosure Standards of 2 public companies- A Tale of 2 Stories: Perrigo and Taro

Being a public company TARO Story is virtually unknown to market participants This explains the mispricing of TARO's shares Disclosure Standards Comparison - Last 2 years PERRIGO TARO Not attended single Investor Conference Not a single Earnings Quarterly Conference Call No No No No Not a single analyst covers Low

Regulary attends Investor Conferences Conducts Earnings Quarterly Conference Call Provides Sales/Earnings guidance Provides Specific drugs in Pipeline and Sales as well as Potential OTC Switches Announces products launch as they happen in 8K Website has an Investor presentation Analyst Coverage Investor Relations Responsiveness

Yes. Yes Yes Yes Yes Yes Yes High

See Investor site See Investor site Slide 25-Perrigo preso Slide 15-perrigo preso (Eg: No 6k on SNDA approval of Daranide )

7 Analyst firms cover Perrigo

Perrigo preso- -http://www.perrigo.com/uploadedFiles/Investors/Presentations/120308%20Bay%20Crest%20Call.pdf Investor site - http://www.perrigo.com/investors/presentations/presentation.aspx?id=1693

http://finance.yahoo.com/q/sa?s=PRGO+Star+Analysts